NCT00003837 2013-06-20506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaNational Cancer Institute (NCI)Phase NA Completed25 enrolled